Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience.

Miano, M; Cuzzubbo, D; Terranova, P; Giardino, S; Lanino, E; Morreale, G; Castagnola, E; Dini, G; Faraci, M

Miano, M; Cuzzubbo, D; Terranova, P; Giardino, S; Lanino, E; Morreale, G; Castagnola, E; Dini, G; Faraci, M.

Affiliation

Miano M; Department of Paediatric Haematology/Oncology, G Gaslini Research Institute, Genoa, Italy.

Bone Marrow Transplant ; 43(5): 423-7, 2009 Mar.

Article in En | MEDLINE | ID: mdl-18850021

Subject(s)

Antibodies, Monoclonal/therapeutic use; Graft vs Host Disease/drug therapy; Hematopoietic Stem Cell Transplantation/adverse effects; Immunoglobulin G/therapeutic use; Immunosuppressive Agents/therapeutic use; Acute Disease; Antibodies, Monoclonal, Humanized; Child; Daclizumab; Female; Humans; Male; Transplantation, Homologous

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Immunosuppressive Agents / Antibodies, Monoclonal Limits: Child / Female / Humans / Male Language: En Journal: Bone Marrow Transplant Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google